Clinical outcome of autologous spongiosa grafts and autologous matrix induced chondrogenesis in osteochondral lesions of the talus

• Conditions: Osteochondritis dissecans tali; M93.2; Osteochondritis dissecans

• Registration Number: DRKS00005100
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-05-15
• Study Completion: 2014-09-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Patients (male and female) between 18 and 65 years with osteochondritis dissecans tali and Surgery between 2007 and 2012 (autologous spongiosa grafts and autologous matrix induced chondrogenesis).

Exclusion Criteria

younger than 18, older than 65, patients who cannot give their consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
AOFAS, FFI Scores (concerning Pain, quality of Life) in Patients treated with autologous spongiosa grafts and autologous matrix induced chondrogenesis in osteochondral lesions of the talus. Point in time of evaluation: 2nd quarter of 2013 (follow-up examination at least one year postoperative).

Secondary Outcome Measures

Name	Time	Method
VAS (Pain), complications after autologous spongiosa grafts and autologous matrix induced chondrogenesis in osteochondral lesions of the talus. Point in time of evluation: 2nd quarter of 2013 (follow-up examination).